- Medicover
- Diagnostic tests
- Blood tests
- Ovarian reserve - AMH hormone
Ovarian reserve - AMH hormone
The AMH (anti-mullerian hormone) test is an important part of a woman's fertility assessment. It can also help diagnose premature ovarian insufficiency. Check your fertility with a simple test!
Buy cheaper - join MediClub and pay 5% less.
+ Material fee
Lowest price from 30 days before discounting PLN 209.00Do you want to learn more about your fertility? Do you want to plan motherhood? Or maybe you are hesitating about having a baby or are afraid that you have reached the age where you may have difficulty getting pregnant? Take a simple test and find out the answer!
Women, unlike men who produce sperm continuously, are born with a finite number of eggs, which means that their time to decide to have a child is limited by each ovulation during which a mature egg is released. This, combined with the aging of the egg cells, causes women's fertility to decline with age. By assessing the ovarian reserve, i.e. checking how many eggs are ready for further development, it is possible to determine whether a woman still has time to postpone conception. These tests also play a huge role in the diagnosis and treatment of infertility.
The assessment of ovarian reserve can be done through laboratory tests and checking the concentration of the hormone used to assess ovarian reserve - AMH (Anti-Müllerian hormone).
Anti-Müllerian Hormone, abbreviated AMH is a hormone that in women of reproductive age participates in the selection of the dominant follicle, i.e. the one that will "release" the egg during ovulation. It is produced by granulosa cells in follicles with immature egg cells accumulated in the ovaries, thanks to which it is used to assess a woman's ovarian reserve.
AMH peaks between the ages of 21 and 30, and gradually decreases over time. The higher the AMH level, the more ovarian reserve a woman has, meaning the more follicles (in which an egg can mature and be released during ovulation) she has in her ovaries. During infertility treatment, the level of AMH is taken into account when planning the procedure - low levels of this hormone may be an indication for in vitro fertilization.
Undetectable or very low levels of AMH indicate depletion of ovarian reserve and are predictive of menopause in approximately 5 years or, if present in a young woman, may suggest premature ovarian failure (commonly referred to as "premature menopause"). In turn, too high AMH levels may indicate polycystic ovary syndrome, also known as PCOS for short.
Your benefits:
- You will be know more about your fertility.
- You will find out if you can wait before making a decision to have a child.
- You will avoid the costs and time that you would have to spend on a doctor's visit qualifying for tests.
Additional information:
- This product is for women only.
- Fertility is a complex mechanism, therefore the results should be analysed by a physician and should not be used as a basis for diagnosis.
The test can be done at any time because the AMH level is constant and does not depend on the phase of the cycle and is not affected by hormonal therapy or contraception.
Results will be available within 3 business days. You can collect them at the reception desk of the medical centre where the examination was performed or through the Medicover OnLine app.
Others also bought

Liquid-based cytology detects about 64% more high-risk lesions than conventional cytology and enables the early detection of human papillomavirus (HPV) infection – the virus that causes cervical cancer. Meanwhile, LBC with HPV-14 genotyping also makes it possible to determine the specific HPV type that can lead to cancer, making it easier to assess risk and increasing the chances of a complete cure.

A test that gives a more accurate result than cytology performed using the conventional method.